Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Modelling the efficacy of CAR-CIK cell immunotherapy targeting MET-expressing mesothelioma cells
Related
- Targeting mutant NPM1-expressing AML with T cell receptor-like antibodies
- Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non‐Small Cell Lung Cancer: Mechanisms to Clinical Translation
- Biomimetic mycobacterial dual spatiotemporal targeting induces trained immunity for tuberculosis photothermal immunotherapy and relapse prevention
- Targeting alpha-ketoglutarate starvation within the tumor-immune microenvironment rescues T cell effector function in cancer immunotherapy
- Editorial: The insights of multi-omics into the microenvironment after tumor metastasis: a paradigm shift in molecular targeting modeling and immunotherapy for advanced cancer patients, volume II
BibTeX
@article{padovano2026modelling,
title = {{Modelling the efficacy of CAR-CIK cell immunotherapy targeting MET-expressing mesothelioma cells}},
author = {Federica Padovano and Andrea Maria Lombardi and Silvia Novello and Tommaso Lorenzi and Elisa Vigna and Emma Leschiera and Chiara Villa},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-64219-y},
url = {https://www.nature.com/articles/s41598-026-64219-y},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Modelling the efficacy of CAR-CIK cell immunotherapy targeting MET-expressing mesothelioma cells
AU - Federica Padovano
AU - Andrea Maria Lombardi
AU - Silvia Novello
AU - Tommaso Lorenzi
AU - Elisa Vigna
AU - Emma Leschiera
AU - Chiara Villa
PY - 2026
DA - 2026/10/01
JO - Scientific Reports
DO - 10.1038/s41598-026-64219-y
UR - https://www.nature.com/articles/s41598-026-64219-y
SN - 2045-2322
ER -